Literature DB >> 30766772

Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease.

Hans L Tillmann1, Huiman X Barnhart2, Jose Serrano3, Don C Rockey4.   

Abstract

PURPOSE OF REVIEW: Drug induced liver injury (DILI) is a complex diagnosis dominantly based of exclusion. RECENT
FINDINGS: Currently available causality assessment instruments are considered to be suboptimal. Expert opinion appears to be best method to adjudicate causality, but is impractical to implement on a wide scale basis. Thus, new approaches are needed, for example improving the specificity of current scoring systems. A further option would be to develop a system that utilizes computer-based scoring - which would reduce human error. Additionally, it would be ideal to have available drug specific scoring systems, based on drugs' characteristic "phenotypes" (presentation and pattern of injury). Eventually, a validated system could be integrated within the electronic health information system.
SUMMARY: This review highlights an avenue to an improved Causality Assessment Tool.

Entities:  

Keywords:  Causality; Drug induced liver injury; liver disease; scoring system

Year:  2018        PMID: 30766772      PMCID: PMC6369523          DOI: 10.1007/s11901-018-0416-8

Source DB:  PubMed          Journal:  Curr Hepatol Rep        ISSN: 2195-9595


  31 in total

1.  Transaminase elevation on placebo during phase I trials: prevalence and significance.

Authors:  P Rosenzweig; N Miget; S Brohier
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Effect of hospitalisation on liver enzymes in healthy subjects.

Authors:  H Narjes; G Nehmiz
Journal:  Eur J Clin Pharmacol       Date:  2000-07       Impact factor: 2.953

3.  Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting.

Authors:  Hajime Takikawa; Yoriyuki Takamori; Teru Kumagi; Morikazu Onji; Masaaki Watanabe; Akitaka Shibuya; Akiko Hisamochi; Ryukichi Kumashiro; Tadashi Ito; Yasuhide Mitsumoto; Atsushi Nakamura; Takashi Sakaguchi
Journal:  Hepatol Res       Date:  2003-11       Impact factor: 4.288

4.  An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities.

Authors:  F DE RITIS; M COLTORTI; G GIUSTI
Journal:  Clin Chim Acta       Date:  1957-02       Impact factor: 3.786

Review 5.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

6.  The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009.

Authors:  Bo Hovstadius; Göran Petersson
Journal:  Health Policy       Date:  2012-11-26       Impact factor: 2.980

7.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

Authors:  Raúl J Andrade; M Isabel Lucena; M Carmen Fernández; Gloria Pelaez; Ketevan Pachkoria; Elena García-Ruiz; Beatriz García-Muñoz; Rocio González-Grande; Angeles Pizarro; José Antonio Durán; Manuel Jiménez; Luis Rodrigo; Manuel Romero-Gomez; José María Navarro; Ramón Planas; Joan Costa; Africa Borras; Aina Soler; Javier Salmerón; Rafael Martin-Vivaldi
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

8.  High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study.

Authors:  S Chan; E Kingwell; J Oger; E Yoshida; H Tremlett
Journal:  Mult Scler       Date:  2010-12-10       Impact factor: 6.312

9.  Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Authors:  Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

10.  Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

Authors:  James Rochon; Petr Protiva; Leonard B Seeff; Robert J Fontana; Suthat Liangpunsakul; Paul B Watkins; Timothy Davern; John G McHutchison
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

View more
  2 in total

Review 1.  Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-29       Impact factor: 5.810

Review 2.  Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.

Authors:  Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.